UK's NICE (National Institute for Clinical Excellence) appraisal of childhood inhalers appealed
This article was originally published in Clinica
Draft guidance issued by the UK's health technology assessment body, the National Institute for Clinical Excellence (NICE), on inhaler systems for childhood asthma, has been appealed. In line with stated policy, NICE will not comment on the appraisal nor on the nature of the appeal, which was heard on August 31, until it issues its final guidance - due in mid-September at the earliest.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Commissioner Hahn’s tweet announcing a return to inspections, while not a new policy, may be signal that FDA understands sponsor concerns with the agency’s limited ability to conduct onsite inspections. Effort may be aimed at reassuring industry even as CRLs related to manufacturing increase.
Rushed final rule seeking to impose draconian cuts on drug reimbursement rates in the Medicare Part B program is certain to face legal and political obstacles. But the data included on international price benchmarks will still have an impact.